Patents by Inventor Pierre Der Bruggen

Pierre Der Bruggen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated proteins MAGE-4 and MAGE-41
    Publication number: 20060127356
    Abstract: The invention relates to nucleic acid molecules which code for the tumor rejection antigen precursor MAGE-3. Also disclosed are vectors, cell lines, and so forth, which utilize the nucleic acid molecule, and optionally, molecules coding for human leukocyte antigen HLA-A1. Uses of these materials in therapeutic and diagnostic contexts are also a part of the invention.
    Type: Application
    Filed: October 17, 2005
    Publication date: June 15, 2006
    Inventors: Beatrice Gaugler, Benoit Eynda, Pierre der Bruggen, Thierry Boon-Falleur
  • Isolated peptide which binds to HLA-Cw*07 and uses thereof
    Publication number: 20050226881
    Abstract: Peptides which consist of amino acid sequences found in MAGEA3 bind to HLA-Cw*07 molecules to form T cell epitopes. The therapeutic and diagnostic ramifications of this are the subject of this invention, as are various products obtained in the course of the development of the invention.
    Type: Application
    Filed: September 15, 2004
    Publication date: October 13, 2005
    Inventors: Pierre Der Bruggen, Thierry Falleur, Karine Breckpot, Kris Thielemans